What is EPGNF's gross margin?

Epigenomics (EPGNF) has a gross margin of 90% and a net margin of 2802%.

What is EPGNF's P/E ratio?

Track Epigenomics (EPGNF) P/E ratio, ROE, and valuation metrics over time.

Where can I see EPGNF's full financials?

See Epigenomics (EPGNF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Epigenomics (EPGNF) Financials — Revenue, Earnings, Cash Flow

Also trades as: ECX.DE (XETRA) · $vol 0M · EPGNY (OTC) · $vol 0M

$1.12

+0.00 (+0.00%)

OTC · Healthcare · Medical - Specialties · Tech Score Sell · Power 39 · $1.0M mcap · 759244 float · 0.073% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$0M

Revenue

-30.1% YoY

$-4M

Net Income

+62.9% YoY

$-6M

Free Cash Flow

+57.3% YoY

89.6%

Gross Margin

2924.5%

Op. Margin

2801.6%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-414.0%

ROA-31.1%

ROIC-186.5%

Valuation

P/E-0.0

P/B0.3

EV/EBITDA0.0

Leverage

Debt/Equity-1.48

Current Ratio9.03

Interest Cov.-586.4x

Quality Scores

Piotroski F3/9

Altman Z—

Beneish M2.95